Cibus to Participate in the 13th Annual Roth Technology Conference

CBUS 11.18.2024

Full Press ReleaseSEC FilingsOur CBUS Tweets

About Gravity Analytica

Recent News

  • 01.23.2025 - Sidoti Micro Cap Conference
  • 01.22.2025 - Cibus to Participate in the Sidoti Micro Cap Conference
  • 01.21.2025 - Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq’s Minimum Price in Accordance with Nasdaq Rules

Recent Filings

  • 01.22.2025 - 8-K Current report
  • 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.21.2025 - 424B5 Prospectus [Rule 424(b)(5)]

SAN DIEGO,Nov. 18, 2024(GLOBE NEWSWIRE) --Cibus, Inc.(Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced thatRory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will participate in the 13thAnnualRoth Technology Conference.

The conference is being held inNew York CityonNovember 19-20, 2024. Cibus is available for meetings on both days of the conference. Conference attendees should reach out to the Company or their conference host representative to schedule.

About Cibus

Cibus is a leading independent plant trait company that develops and licenses plant traits to seed companies for royalties. Cibus is not a seed company, but rather a technology company that uses its proprietary gene editing technology to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus’ strategy is focused on commercializing productivity traits for the world’s major row crops with large acreage such as: canola, rice, soybean, corn and wheat. The Company targets traits that help manage farmers’ seed productivity, economics and sustainability challenges such as weeds, disease, and insects. TheUnited Nationsestimates that the impacts from these challenges cost the global economy approximately$300 billionannually. Cibus has a current portfolio of six traits, three of which are in commercial development and four of which are multi-crop traits associated with weed management and disease, including Sclerotinia resistance and a new weed management trait which are in advanced greenhouse and field trial stages.

CIBUS CONTACTS:

INVESTOR RELATIONSKaren Troeberktroeber@cibus.com858-450-2636

Jeff Sonnek– ICRjeff.sonnek@icrinc.com

MEDIA RELATIONSmedia@cibus.com

Colin Sanfordcolin@bioscribe.com203-918-4347

Primary Logo

Source: Cibus US LLC

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com